To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
To demonstrate the relative bioequivalence of Cefdinir and Omnicel 300 mg capsule fasting conditions.
Epistemonikos ID: e6b468d34f41e9627cecd27097c0054a6c449c07
First added on: May 05, 2024